EyePoint Pharmaceuticals, Inc. — Director's Dealing 2016

Jul 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2016-07-21

Reporting Person: Ross Leonard S (Vice President, Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-21	Employee Stock Option (right to buy)	$3.49	A	95000	Acquired	2026-07-21	Common Stock (95000)	Direct

Footnotes

F1: The option becomes exercisable in four equal annual installments beginning on the first anniversary of the date of grant.